Which property of buprenorphine explains its safer respiratory profile?

Study for the Pain, Opioids, and Neuropsychiatric Pharmacology Test. Explore with flashcards and multiple choice questions; each query comes with hints and explanations. Prepare to excel in your exam!

Multiple Choice

Which property of buprenorphine explains its safer respiratory profile?

Explanation:
The main idea is that buprenorphine acts as a partial agonist at the mu opioid receptor, and this creates a ceiling effect for respiratory depression. As you raise the dose, receptor activation increases only up to a point and then plateaus, so further increases in dose don’t proportionally worsen breathing. This plateau makes its respiratory depressant effects safer than those of full opioid agonists. While its high affinity and partial agonism are related to this behavior, the key clinically relevant feature is the ceiling effect. The other ideas (complete reversal by naloxone, a non-opioid mechanism) don’t explain why respiratory depression stops increasing, which is why the ceiling effect is the best answer.

The main idea is that buprenorphine acts as a partial agonist at the mu opioid receptor, and this creates a ceiling effect for respiratory depression. As you raise the dose, receptor activation increases only up to a point and then plateaus, so further increases in dose don’t proportionally worsen breathing. This plateau makes its respiratory depressant effects safer than those of full opioid agonists. While its high affinity and partial agonism are related to this behavior, the key clinically relevant feature is the ceiling effect. The other ideas (complete reversal by naloxone, a non-opioid mechanism) don’t explain why respiratory depression stops increasing, which is why the ceiling effect is the best answer.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy